Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent Shareholders Equity (Quarterly): 1.121B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.121B |
| June 30, 2024 | 637.04M |
| March 31, 2024 | 675.04M |
| December 31, 2023 | 700.56M |
| September 30, 2023 | 395.98M |
| June 30, 2023 | 421.15M |
| March 31, 2023 | 443.97M |
| December 31, 2022 | 462.98M |
| Date | Value |
|---|---|
| September 30, 2022 | 236.58M |
| June 30, 2022 | 252.98M |
| March 31, 2022 | 268.92M |
| December 31, 2021 | 285.04M |
| September 30, 2021 | 301.13M |
| June 30, 2021 | -47.74M |
| March 31, 2021 | 12.14M |
| December 31, 2020 | -31.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-47.74M
Minimum
Jun 2021
1.121B
Maximum
Sep 2024
383.47M
Average
348.55M
Median
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics Inc | 911.45M |
| Bristol-Myers Squibb Co | 17.14B |
| Replimune Group Inc | 381.46M |
| Moderna Inc | 11.93B |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.189B |
| Total Liabilities (Quarterly) | 67.73M |